MBX Biosciences

OverviewSuggest Edit

MBX Biosciences is a biotechnology company intended to develop therapies for endocrine diseases. The company specializes in the research and development of endocrine therapeutic drugs by advancing peptide hormone analog studies, thereby allowing the healthcare industry to treat rare endocrine issues.
HQCarmel, IN, US

Latest Updates

Employees (est.) (Nov 2021)11
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at MBX Biosciences

Kent Hawryluk

Kent Hawryluk

President & CEO, Director
Tim Knickerbocker

Tim Knickerbocker

Chief Operating Officer
Richard Dimarchi

Richard Dimarchi

Chief Scientific Officer, Director
Greg Davis

Greg Davis

Vice President, Product Development
Lisa Redman

Lisa Redman

Vice President, Finance
Mary Jane Geiger

Mary Jane Geiger

Chief Medical Officer
Show more

MBX Biosciences Office Locations

MBX Biosciences has an office in Carmel
Carmel, IN, US (HQ)
11711 N Meridian St #310
Show all (1)

MBX Biosciences Financials and Metrics

Summary Metrics

Founding Date


MBX Biosciences total Funding

$34.6 m

MBX Biosciences latest funding size

$34.6 m

Time since last funding

a year ago

MBX Biosciences investors

MBX Biosciences's latest funding round in July 2020 was reported to be $34.6 m. In total, MBX Biosciences has raised $34.6 m
Show all financial metrics

MBX Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

MBX Biosciences Online and Social Media Presence

Embed Graph

MBX Biosciences News and Updates

MBX Biosciences Closes $34.6M Series A Financing

MBX Biosciences, a Carmel, Ind.-based drug discovery company focused in rare endocrine diseases, closed a $34.6m Series A financing. The round was led by Frazier Healthcare Partners, with participation from OrbiMed, New Enterprise Associates, Indiana Philanthropic Venture Fund (IU PhV), Indiana Seed…

MBX Biosciences Frequently Asked Questions

  • When was MBX Biosciences founded?

    MBX Biosciences was founded in 2018.

  • Who are MBX Biosciences key executives?

    MBX Biosciences's key executives are Kent Hawryluk, Tim Knickerbocker and Richard Dimarchi.

  • How many employees does MBX Biosciences have?

    MBX Biosciences has 11 employees.

  • Who are MBX Biosciences competitors?

    Competitors of MBX Biosciences include Azeria Therapeutics, Pathios Therapeutics and Pinteon Therapeutics.

  • Where is MBX Biosciences headquarters?

    MBX Biosciences headquarters is located at 11711 N Meridian St #310, Carmel.

  • Where are MBX Biosciences offices?

    MBX Biosciences has an office in Carmel.

  • How many offices does MBX Biosciences have?

    MBX Biosciences has 1 office.